Home/BioGenCell/Yael Porat, PhD
YP

Yael Porat, PhD

Founder, CEO & CSTO

BioGenCell

BioGenCell Pipeline

DrugIndicationPhase
BGC101Chronic Limb‑Threatening Ischemia (CLTI)Phase 2
BGC10XBroad Microvascular Unmet NeedsPreclinical